共 9 条
[1]
Association between protease in hibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a system atic review. Rhew DC,Bernal M,Aguilar D,et al. Clinical Infectious Diseases . 2003
[2]
Graham NM. JAIDS Journal of Acquired Immune Deficiency Syndromes . 2000
[3]
Mitochnodrial toxicity in the era of HA ART: evaluating venous lactate and peripheral blood mitochnodrial DNA in HIV-infected patients taking antiretr oviral therapy. Montaner IS,Cote HC,Harris M. JAIDS Journal of Acquired Immune Deficiency Syndromes . 2003
[4]
Host factors maybe more important than choice of antiretrovirals in the development of lipoatrophy. McComsey G,Maa JF. AIDS Read . 2003
[5]
Penzak SR,Chuck SK. Scandinavian Journal of Infectious Diseases . 2000
[6]
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV- infected patients. Corzo JE,Gomez- Mateos J,Rueda A. HIV Clinical Trials . 2003
[7]
Toxicity of non - nucleoside analogue reve rse transcriptase inhibitors. Kontorinis N,Dieterich DT. Seminars in Liver Disease . 2003
[8]
Elevated blood pressure in HIV-infected individuals receiving highly active antir etroviral therapy. Chow DC,Souza SA,Chen R. HIV Clinical Trials . 2003
[9]
Hyperlactataemia during antiretrovir al therapy: incidences, clinical data and treatment. Gerard Y,Viget N,Yazdanpanah Y. Therapie . 2003